RTOG 0525 - Phase III Trial Comparing Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma.

Clinical Trial Categories

• Brain Cancer

Contact

The Rosenfeld Cancer Center at 215-481-2402